Mingli Xiang

3.1k total citations
69 papers, 2.6k citations indexed

About

Mingli Xiang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mingli Xiang has authored 69 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 20 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Mingli Xiang's work include Synthesis and biological activity (12 papers), Computational Drug Discovery Methods (10 papers) and Nanoparticle-Based Drug Delivery (6 papers). Mingli Xiang is often cited by papers focused on Synthesis and biological activity (12 papers), Computational Drug Discovery Methods (10 papers) and Nanoparticle-Based Drug Delivery (6 papers). Mingli Xiang collaborates with scholars based in China, United States and Canada. Mingli Xiang's co-authors include Yuquan Wei, Maling Gou, Zhiyong Qian, Lijuan Chen, Shengyong Yang, Liang Ma, Shaochen Chen, Wei Zhu, Ke Men and Jia Song and has published in prestigious journals such as Nature Communications, PLoS ONE and Biomaterials.

In The Last Decade

Mingli Xiang

68 papers receiving 2.6k citations

Peers

Mingli Xiang
Sherine N. Khattab Egypt
Hojjat Sadeghi‐Aliabadi Iran
V. Badireenath Konkimalla India
Francesca Greco United Kingdom
Hai Qian China
Siyu He China
Arvind K. Singh Chandel India
Abolfazl Barzegar Iran
Tian Xie China
Deep Pooja India
Sherine N. Khattab Egypt
Mingli Xiang
Citations per year, relative to Mingli Xiang Mingli Xiang (= 1×) peers Sherine N. Khattab

Countries citing papers authored by Mingli Xiang

Since Specialization
Citations

This map shows the geographic impact of Mingli Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingli Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingli Xiang more than expected).

Fields of papers citing papers by Mingli Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingli Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingli Xiang. The network helps show where Mingli Xiang may publish in the future.

Co-authorship network of co-authors of Mingli Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingli Xiang. A scholar is included among the top collaborators of Mingli Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingli Xiang. Mingli Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiang, Mingli, et al.. (2024). Summer Thermal Challenges in Emergency Tents: Insights into Thermal Characteristics of Tents with Air Conditioning. Buildings. 14(3). 710–710. 1 indexed citations
2.
Zhang, Chufeng, Yong Li, Minghai Tang, et al.. (2021). Discovery of 3-(4-(2-((1H-Indol-5-yl)amino)-5-fluoropyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile Derivatives as Selective TYK2 Inhibitors for the Treatment of Inflammatory Bowel Disease. Journal of Medicinal Chemistry. 64(4). 1966–1988. 16 indexed citations
3.
Yang, Tao, Yong Chen, Mingli Xiang, et al.. (2020). N-(Pyrimidin-2-yl)-1,2,3,4-tetrahydroisoquinolin-6-amine Derivatives as Selective Janus Kinase 2 Inhibitors for the Treatment of Myeloproliferative Neoplasms. Journal of Medicinal Chemistry. 63(23). 14921–14936. 13 indexed citations
4.
5.
Yang, Tao, Zhuang Yang, Minghai Tang, et al.. (2019). Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms. Journal of Medicinal Chemistry. 62(22). 10305–10320. 31 indexed citations
6.
7.
Yang, Shuping, Xiang Gao, Yihong He, et al.. (2019). Applying an innovative biodegradable self-assembly nanomicelles to deliver α-mangostin for improving anti-melanoma activity. Cell Death and Disease. 10(3). 146–146. 16 indexed citations
8.
Pei, Heying, Linhong He, Mingfeng Shao, et al.. (2018). Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis. Scientific Reports. 8(1). 5273–5273. 33 indexed citations
9.
10.
Gao, Xiang, Shimin Wang, Bilan Wang, et al.. (2015). Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations. Biomaterials. 53. 646–658. 51 indexed citations
11.
Ran, Yan, Heying Pei, Caifeng Xie, et al.. (2015). Scaffold-based design of xanthine as highly potent inhibitors of DPP-IV for improving glucose homeostasis in DIO mice. Molecular Diversity. 19(2). 333–346. 5 indexed citations
12.
13.
Wang, Guangcheng, Chunyan Li, Lin He, et al.. (2014). Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Bioorganic & Medicinal Chemistry. 22(7). 2060–2079. 100 indexed citations
14.
Xiang, Mingli, Kai Lei, Yu‐Chun Lin, et al.. (2013). In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features. Drug Design Development and Therapy. 7. 789–789. 13 indexed citations
15.
16.
Xiang, Mingli, et al.. (2012). Computer-Aided Drug Design: Lead Discovery and Optimization. Combinatorial Chemistry & High Throughput Screening. 15(4). 328–337. 65 indexed citations
17.
Gou, Maling, Ke Men, Shi H, et al.. (2011). Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale. 3(4). 1558–1558. 348 indexed citations
18.
Zou, Jun, et al.. (2008). Detailed conformational dynamics of juxtamembrane region and activation loop in c‐Kit kinase activation process. Proteins Structure Function and Bioinformatics. 72(1). 323–332. 23 indexed citations
19.
Zhang, Hui, Mingli Xiang, Yinglan Zhao, Yuquan Wei, & Shengyong Yang. (2008). Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors. European Journal of Pharmaceutical Sciences. 36(4-5). 451–457. 15 indexed citations
20.
Wang, Huiyuan, Yinglan Zhao, Mingli Xiang, et al.. (2008). Pharmacophore Modelling and Virtual Screening for Identification of New Aurora‐A Kinase Inhibitors. Chemical Biology & Drug Design. 71(6). 533–539. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherine N. Khattab Breakdown of academic impact, for papers by Hojjat Sadeghi‐Aliabadi Breakdown of academic impact, for papers by V. Badireenath Konkimalla Breakdown of academic impact, for papers by Francesca Greco Breakdown of academic impact, for papers by Hai Qian Breakdown of academic impact, for papers by Siyu He Breakdown of academic impact, for papers by Arvind K. Singh Chandel Breakdown of academic impact, for papers by Abolfazl Barzegar Breakdown of academic impact, for papers by Tian Xie Breakdown of academic impact, for papers by Deep Pooja
Rankless by CCL
2026